Healthtech Startups

Viedoc offers electronic data capture (EDC) software for clinical trial management that features visual design tools, API integrations with existing trial systems, and regulatory compliance features.

1 investor

BihlerMed manufactures LED surgical lights and provides contract manufacturing and design services for medical devices, including prototyping, engineering, and regulatory compliance support. The company operates a state-of-the-art facility in Phillipsburg, New Jersey and serves medical device manufacturers and practitioners.

1 investor

The Global Alzheimer's Platform Foundation is a nonprofit organization that reduces the time and cost of clinical trials for Alzheimer's and Parkinson's disease by coordinating multi-site research networks and providing trial management, data, and participant recruitment services. It serves pharmaceutical sponsors, contract research organizations, and clinical research sites seeking to accelerate neurodegenerative disease drug development.

1 investor

Vieworks develops imaging technology including machine vision cameras, high-speed CoaXPress-over-fiber solutions, X-ray detectors, radiography acquisition software, and digital pathology scanners. Its products serve industrial machine vision, medical radiography, and pathology markets.

1 investor

Vigil Health Solutions provides a care platform that supports multiple levels of care, designed to scale with resident populations.

1 investor

1 investor

Vigor delivers home-based, remotely monitored chronic disease and rehabilitation care using connected devices, AI, and multi-disciplinary care teams. It also offers the Vigor Command Center, a care coordination platform for clinicians and care teams to manage patients at scale.

1 investor

Vigurus Technologies develops SP1KE™, a protective materials technology platform designed for impact mitigation and flexible, lightweight protection across sports equipment, transportation, construction, and other industrial applications.

1 investor

Viking Therapeutics is a clinical-stage biopharmaceutical company developing therapies in areas such as metabolic and endocrine disorders. This page presents its board of directors.

1 investor

VillageMD is a primary care platform providing high-quality community-based healthcare services across the United States, focusing on preventive care and chronic disease management. The company operates Village Medical practices, some co-located with Walgreens pharmacies, and offers virtual and home-based care services.

1 investor

VilMer is a Norwegian technology company offering VilMer Aktivitetsplan, a digital "Activity-as-a-Service" platform that connects elderly residents and care services with volunteers, everyday companions, relatives, and digital activities. It serves nursing homes, day-care programs, assisted-living and senior housing across Norway, Sweden, and Denmark to increase activity and social contact for the elderly while relieving healthcare staff.

1 investor

Vine Medical develops soft robotic medical devices designed to enhance clinician safety and outcomes during procedures. Their initial product, the Origin Intubation System, is a soft robot that guides airway navigation with a design that makes safe actions the default without relying on software.

1 investor

VintaBio provides viral vector manufacturing for clinical and commercial gene therapies, using a single-stream process (VintaProcess) to produce high-yield, high-purity vectors. It offers end-to-end services from discovery through final delivery for cell and gene therapy developers.

1 investor

Violet provides free, personalised support for Australian families navigating end-of-life care, combining human connection and technology to offer practical guidance, emotional support, and tools for important conversations. The platform serves anyone in Australia preparing for or experiencing the final stage of life.

1 investor

Viralgen provides contract manufacturing services for AAV-based gene therapy, supporting early-phase preclinical and clinical production with a platform designed for regulatory compliance and batch scalability. The company serves gene therapy developers pursuing treatments for rare diseases.

1 investor

Viramal develops proprietary products for women's sexual, vaginal, and reproductive health using its Fem Med Tech platform. The company targets unmet needs in women's healthcare through a clinically-led approach.

1 investor

The first talent-as-a-service platform that supports clinical research globally.

1 investor

Virica develops small-molecule cell enhancers called Viral Sensitizers (VSE) that temporarily reduce host cell defenses to increase viral vector yields, quality, and scalability during production. Its products serve cell and gene therapy and vaccine manufacturers, aiming to lower manufacturing costs and improve patient access.

1 investor

Virilitas Labs develops research-led technologies focused on male fertility and reproductive health, drawing on over 20 years of study in reproduction and genetics. It aims to translate scientific research into products supporting couples with male infertility challenges.

1 investor

Virility Medical develops products and services for sexual wellness using medical technology and clinical research. The company serves individuals seeking science-based intimate health solutions.

1 investor

Virogin develops oncolytic virus therapies and mRNA vaccines for cancer treatment, combining immunotherapy approaches to create immuno-oncology therapeutics for patients with serious cancers.

1 investor

Vironexis is a clinical-stage biotechnology company developing an in vivo protein engineering platform called TransJoin, which uses non-integrating AAV vectors to instruct a patient's liver to continuously secrete bispecific T-cell engagers from a single IV dose. Its pipeline targets hematologic malignancies, solid tumors, and immune disorders, with lead candidates VNX-101 (CD19+ leukemias and lymphomas) and VNX-202 (HER2+ cancers) in Phase 1/2 clinical trials.

1 investor

Virta offers a personalized nutrition program combined with expert clinical support and technology to help people reverse type 2 diabetes, prediabetes, and obesity and achieve sustainable weight loss. The program is aimed at individuals with metabolic conditions and is backed by clinical research, including a large type 2 diabetes reversal study, primarily in the U.S. market.

1 investor

Virta Labs builds an API-first, open-core security platform for healthcare IT infrastructure, including BlueFlow asset management, Tapirx passive medical device discovery, and VulnFWRD AI risk orchestration. It serves hospitals and health systems, providing device inventory, safe vulnerability scanning, SBOM generation, and closed-loop remediation for medical devices in the United States.

1 investor